RecruitingNCT07714863
Respiratory
Allergic bronchopulmonary aspergillosis
11
studies recruiting now
as of 7 Sept 2026
49
studies registered in total
as of 7 Sept 2026
1
countries with a recruiting site
as of 7 Sept 2026
20 Jul 2026
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT07690345
Fungal Status and Prognosis in ABPA
RecruitingNCT07611838
Multi-Omics Inflammatory Phenotype for ABPA Recurrence Risk Prediction
RecruitingNCT07530770
Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary Aspergillosis
RecruitingNCT07362693
A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 11 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Allergic bronchopulmonary aspergillosis study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Allergic bronchopulmonary aspergillosis
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
7 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Phase 3Itraconazole (Fungitraxx)
Phase 3Prednisolone (Cortalone)
Phase 3Ibrexafungerp
Phase 2/3Amphotericin B (Abelcet)
Phase 2/3Voriconazole (Vfend)
Phase 2/3Budesonide (Aircort)
Phase 2Dupilumab (Dupixent)
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).